• myTrident, the domestic home furnishing brand of Trident enters the luxury home furnishings market with the launch of LUXEHOME

• myTrident eyeing growth in the East and South India, with plans to add 500 premium retail points by 2025

Trident Group, a global conglomerate and a leading name in the home textiles industry, today announced ambitious plans at Bharat Tex 2025, targeting a threefold growth by 2027. This aggressive growth is fueled by an INR 1000 crore capital expenditure plan for FY25-26, focusing on sustainability, modernization, and asset enhancement across its home textiles, yarn, and energy businesses.

Hon’ble Union Minister of Textiles, Sh. Giriraj Singh, alongwith Padma Shri Dr. Rajinder Gupta, Chairman Trident Group & Rajneesh Bhatia, CEO myTrident at Bharat Tex 2025

A cornerstone of the growth is the expansion of its domestic home textile brand, myTrident, into the luxury segment with the launch of LUXEHOME by myTrident. This exclusive new line caters to discerning customers who appreciate the finest craftsmanship and unparalleled quality in home textiles. The collection includes a curated selection of premium bedding and exquisitely crafted towels renowned for their superior softness, absorbency, and durability. With a price range of INR 4,000 to INR 40,000, LUXEHOME by myTrident offers a touch of refined elegance for the most discerning homes. This strategic move positions myTrident to capture a significant share of the burgeoning luxury home furnishings market in India.

Padma Shri Dr. Rajinder Gupta, Chairman, Trident Group, shared his vision, stating, “At Trident, we are committed to shaping the future of the textile industry by integrating innovation and sustainability. Our growth is driven by our unwavering focus on modernization, value creation, and global expansion. Bharat Tex 2025 is a landmark event that highlights Indias immense potential as a textile powerhouse, and Trident is proud to contribute to this journey. By investing in advanced technology, sustainable practices, and market-driven solutions, we are not just strengthening our leadership position but also redefining the standards of excellence in the home textile industry.”

Neha Gupta, Chairperson, myTrident, highlighted the brand’s expansion and luxury market entry, saying, “LUXEHOME represents a transformational step for myTrident as we elevate our presence in the luxury home furnishings segment. By leveraging our heritage of craftsmanship and manufacturing excellence, we are bringing world-class luxury to discerning Indian customers. Our focus is on redefining home elegance with meticulously designed, high-quality products that cater to the aspirations of modern Indian homes. We’re thrilled to showcase this collection which aligns with Bharat Tex’s focus on a futuristic and responsible textile industry.”

Commenting on myTrident’s growth plans, Rajneesh Bhatia, CEO of myTrident stated, “We are increasing our retail touch points from the current 7,000 to 10,000. This expansion will solidify our position as a leading home furnishings brand in India and broaden our footprint across the domestic market. To drive further growth, were focusing on key opportunities in HORECA and institutions, aiming to increase our market share in these sectors. Additionally, were exploring opportunities in corporate gifting, recognizing the immense potential in this sector. Speed and agility in serving the consumer remain a core focus for the brand, and thus we are collaborating with all major e-commerce and quick commerce portals.”

Bharat Tex 2025 marked the debut of myTridents Spring Summer 25 collection, which drew inspiration from Indias rich textile heritage. The collection took a journey through four eras – Puratan Yug , Veer Yug, Poorv Aaduhnik Yug, and Unnati Yug- blending traditional craftsmanship with modern techniques and innovative materials to create a forward-looking vision for the future of textiles.

About Trident Group
Trident Limited is the flagship company of Trident Group, an Indian business conglomerate and global player. Headquartered in Ludhiana, Punjab, Trident Limited is a vertically integrated textile (Yarn, Bath & Bed Linen) and Paper (Wheat Straw-based) manufacturer. Tridents towels, yarns, bedsheets, and paper businesses have earned global recognition and are delighting millions of customers across India and the world. Trident is one of the largest players in home textiles in India.

Supplying national, captive, and retailer-owned brands; the organization is highly decorated with awards from its customers, vendors, and various government entities in recognition of advancing the highest standards in product quality, social responsibility, and environmental stewardship.The company operates in three major business segments: Textiles, Paper, and Chemicals, with its manufacturing facilities in Punjab and Madhya Pradesh.

About myTrident
myTrident is a leading brand specializing in luxurious and premium home furnishings. The company caters to all segments, from luxury and premium to everyday needs. With a focus on design, innovation, and sustainability, the brand has been setting benchmarks in the home textile industry. Understanding customer demands, myTrident offers a range of exquisite products, including bed sheets, towels, pillows, top-of-bed articles, bathrobes, and much more. Each item is crafted with precision and attention to detail to offer customers an unparalleled sense of comfort, style, and elegance. myTrident products are available in all leading hotels across the country. The brand is also available on major e-commerce and quick commerce portals and offers a convenient online shopping experience at: www.mytrident.com

Indian Venture and Alternate Capital Association (IVCA) successfully concluded the 14th edition of its flagship event, the IVCA Conclave 2025, in Mumbai. The two-day event brought together policymakers, global and domestic investors, private equity and venture capital leaders, and industry experts to discuss key investment trends, regulatory developments, and growth opportunities in Indias evolving financial ecosystem.

IVCA Conclave 2025 Concludes with Key Discussions on Secondary Markets, Private Credit, and Growth Investing

The first day of the conclave set the stage with critical discussions on Indias investment climate, regulatory developments, and capital allocation strategies. Dr V Anantha Nageswaran, Chief Economic Adviser to the Government of India, provided a macroeconomic perspective on India’s transformation into a global investment hub, while Shri Jayant Sinha, Senior Advisor, IVCA Climate and Sustainability Council, emphasised the importance of long-term strategic planning in India’s evolving investment landscape.

The second day of the conclave opened with an insightful discussion led by Shri K Rajaraman, Chairperson, International Financial Services Centres Authority (IFSCA), on the evolution of GIFT City into a global financial hub. He highlighted how regulatory reforms since 2019 have unified governance across financial sectors, enabling seamless capital movement and reducing reliance on foreign jurisdictions for bond issuance and credit access. The ecosystem now hosts over 30 international banks with assets exceeding $78 billion, offering specialised financial products such as acquisition financing and infrastructure funding.

This was followed by a presentation by Dr Dipesh Shah, Executive Director (Development), IFSCA, highlighting the role of GIFT City in positioning India as a global financial hub.

One of the key highlights of the day was the Panel Discussion: Navigating the Secondary Surge – Unlocking Value in India’s Evolving Investment Landscape, where industry leaders explored the growing momentum of secondary transactions. The discussion focused on LP and GP-led secondaries, valuation strategies, and regulatory considerations shaping this burgeoning market. The panel provided valuable insights into how secondaries are increasingly becoming a preferred liquidity avenue in a constrained deal-making environment.

The day also saw the launch of the IVCA-Praxis Report on Growth Investing, which revealed that private investments in India reached $60 billion across 1,595 deals in 2024, with an average deal size of $38 million. Growth stage investments accounted for $10 billion across 388 deals, marking a record high volume with 150+ additional growth deals compared to 2023. The report highlighted that $600 billion in growth funding is required for Indian companies, presenting a massive opportunity for investors. While fundraising from growth-focused funds declined to $3.2 billion, its share of overall fundraising reached a five-year high of 29%. Public market exits drove 60% of overall exit value, emphasising the growing role of IPOs in unlocking value for investors.

With alternative investment structures gaining prominence, the Panel Discussion: CAT III Funds – Navigating the Investment Landscape examined the role of hedge funds and structured products in India’s financial ecosystem. The panel discussed regulatory frameworks, innovation in fund strategies, and the risk-return profile of these vehicles. Bhautik Ambani, CEO, AlphaGrep Investment Management, stated, “One of the things that CAT III funds offer, which PMS or mutual funds cannot, is superior risk-adjusted returns. No other asset class in India today provides the flexibility to generate better returns with the level of risk taken. CAT III funds provide solutions that other platforms simply cannot.”

Another significant discussion revolved around India’s private credit landscape. The Panel Discussion: Private Credit – Expanding from Niche to Norm in India highlighted the surge in private credit investments, evolving deal structures, and the increasing role of domestic and global investors in this space.

Rubin Chheda, Managing Director, Neo Asset Management, stated, “Private credit in India remains niche, accounting for just 1.3-1.4% of total bank and corporate debt exposure-far behind the U.S., where it constitutes 11-12% of the overall debt market. While the U.S. sees highly structured deals with leverage up to 6x, in India, leverage is typically limited to 3-4x. Unlike global markets where leveraged buyouts (LBOs) dominate, Indias private credit landscape is constrained by regulatory structures that limit capital movement across entities, making deal structuring more complex.”

Anant Khatri, Executive Director (Private Credit Investments), Avendus, emphasized, “Private credit plays a crucial role in sectors where traditional lending models don’t work. Real estate, for instance, requires custom financial solutions based on location, sales velocity, and pricing viability. Over the past 15 years, private credit has transitioned from being dominated by specialized NBFCs to large alternative investment funds. It provides much-needed short-term capital to bridge funding gaps.”

Monu Jain, Partner, Credit, Aavishkar Capital, remarked, “Blended finance is emerging as a powerful tool to attract private capital at lower risks and costs. Public capital, including funds from development finance institutions and multilateral agencies, acts as catalytic capital through grants, concessional loans, and guarantees. ESG-focused private credit remains niche within a niche. While over $700 billion has been allocated globally to sustainability finance in the past decade, private credit makes up just $50 billion. The biggest challenge is the perception that sustainable private credit investments compromise either risk or return.”

As capital markets continue to evolve, the Panel Discussion: Balancing Liquidity and Market Dynamics – The Exit Equation examined exit strategies, IPO trends, and consolidation within sectors as key drivers shaping liquidity. Experts discussed the role of public markets in enabling investor exits and the challenges posed by market volatility.

The conclave concluded with the IVCA Alternate Capital Excellence Awards 2025, recognising outstanding contributions and achievements in the private capital industry.

Supporting IVCA Conclave 2025 as the Lead Sponsors were Aavishkar Capital, Cooley, IC Universal Legal Advocates & Solicitors, Iron Pillar, Nishith Desai Associates, Nuvama Asset Management, and Sundaram Alternates. The Co-Sponsors included Madison India Capital, Neo Asset Management, Oman India Joint Investment Fund, and Playbook.

Over two days, the IVCA Conclave 2025 facilitated in-depth conversations on India’s investment landscape, regulatory shifts, and emerging financial trends, reaffirming its position as a leading platform for stakeholders in the alternative investment space.

About the Indian Venture and Alternate Capital Association (IVCA)
The Indian Venture and Alternate Capital Association (IVCA) is a not-for-profit, apex industry body promoting the alternate capital industry and fostering a vibrant investing ecosystem in India. IVCA is committed to supporting the ecosystem by facilitating advocacy discussions with the Government of India, policymakers, and regulators, resulting in the rise of entrepreneurial activity, innovation, and job creation in India and contributing towards the development of India as a leading fund management hub. IVCA members are the most active domestic and global VCs, PEs, funds for infrastructure, real estate, credit funds, limited partners, investment companies, family offices, corporate VCs, and knowledge partners. These funds invest in emerging companies, venture growth, buyout, special situations, distressed assets, and credit and venture debt, among others.

Eros Innovation, a multi-billion-dollar entertainment powerhouse revolutionizing the media business with artificial intelligence, and OxValue.AI, an Oxford University spin-out specializing in AI-driven technology valuation, are pleased to announce a strategic joint venture aimed at transforming the landscape of technology valuation in India.

Eros Innovation and OxValue.AI come together to announce a Joint Venture to Revolutionize Technology Valuation in India

This collaboration seeks to leverage OxValue.AI’s proprietary Valuation of Early Stage Technology (VEST) Tool, which utilizes advanced data analytics and artificial intelligence to provide accurate and objective valuations of early-stage technologies and start-ups. By integrating this innovative tool with Eros Innovation’s extensive network and industry expertise, the joint venture aims to support India’s burgeoning technology sector by facilitating informed investment decisions and fostering innovation.

Key Objectives of the Joint Venture:

1. Empowering Start-ups and SMEs: Provide accessible and affordable valuation services to small and medium-sized enterprises (SMEs) and start-ups across India, enabling them to attract investment and scale their operations effectively.

2. Facilitating Technology Transfer: Assist in the seamless transfer of technology by providing precise valuations, thereby promoting collaboration between innovators and investors.

3. Supporting Policy and Decision-Making: Offer valuable insights to policymakers and stakeholders to inform strategies that nurture the growth of the technology ecosystem in India.

Kishore Lulla, Chairman of Eros Innovation, commented on the partnership, “We are excited to join forces with OxValue.AI to bring cutting-edge technology valuation services to India. This joint venture aligns with our commitment to fostering innovation and supporting the growth of the technology sector in emerging markets.”

Professor Xiaolan Fu, Founder of OxValue.AI, added,“Our mission has always been to make technology valuation more objective, accurate, and accessible. Partnering with Eros Innovation allows us to extend our reach and impact, particularly in a dynamic and rapidly growing market like India.”

The joint venture will be headquartered in Mumbai, with plans to establish regional offices across major technology hubs in India. Operations are slated to commence in the second quarter of 2025, with an initial focus on sectors such as information technology, biotechnology, and renewable energy.

This partnership underscores a shared vision to drive technological advancement and economic growth in India by providing essential tools and services that empower innovators and investors alike.

Industry leaders have also recognized the potential of OxValue.AI in shaping the future of technology valuation.

“OxValue.AI represents a transformative step forward in the valuation profession. I hope it is an indispensable tool for professionals navigating the Fourth Industrial Revolution.” Said from Nick Talbot, CEO, International Valuation Standards Council.

“OxValue.AI is a game-changer for businesses managing intellectual property offering enterprises a robust tool to drive investment and competitive advantage in the global knowledge economy.” said Ben Llewellyn-Jones, Director, Business and International Policy, UK Intellectual Property Office

About Eros Innovation

Eros Innovation is a multi-billion-dollar entertainment powerhouse, revolutionizing the media business with artificial intelligence. With over a trillion AI tokens powering intellectual property across text, images, and video, the company is pioneering the future of entertainment and digital innovation.

About OxValue.AI

OxValue.AI is an Oxford University spin-out company founded by Professor Xiaolan Fu. The company specializes in utilizing data and AI technology to assess the monetary value of technology and technology-rich start-up companies. Their primary tool, the Valuation of Early Stage Technology (VEST) Tool, leverages various variables, including patent data, to provide objective, accurate, affordable, and accessible valuations. This approach aims to support innovation, assist small and medium-sized enterprises (SMEs), and facilitate technology transfer to developing countries.

Bajaj Markets, a digital financial marketplace, has partnered with CRIF High Mark to help individuals gain deeper insights into their credit behaviour. In accordance with this, individuals can get their credit score on Bajaj Markets from CRIF High Mark for free. This can help borrowers understand their eligibility for various credit products better and choose options that best suit their needs.

Boost to Credit Reach for Indian Consumers

The CRIF High Mark score ranges between 300 – 900. A higher score signifies better creditworthiness, leading to a lower lending risk being associated with the individual. Some of the major elements taken into consideration to determine an individual’s CRIF Highmark credit score include the following:

• Credit utilisation ratio

• Credit applications

• Credit mix

• Credit payment history

• Number of open and closed credit accounts

• Total outstanding debt

Checking the CRIF High Mark score on Bajaj Markets results in a soft credit check which does not impact the score. This makes it easier for individuals to regularly access and monitor their score without having to face any significant impact. Such frequent checks can help individuals understand their credit status and plan for future loan or credit card applications accordingly.

After checking the credit score on Bajaj Markets, individuals can use the score to assess their eligibility for various credit products on the financial marketplace. They can get secured and unsecured loans from over 45 leading loan providers in India. If required, they can choose a credit card which suits their financial needs from over 30 different options.

Individuals can also explore various investment and insurance offers on the digital financial marketplace. For this, they simply need to visit the Bajaj Markets website or download the official app from the Google Play Store or Apple App Store.

About Bajaj Finserv Direct

Bajaj Finserv Direct, a subsidiary of Bajaj Finserv, is one of the fastest-growing fintech companies in India. It has two primary arms, Bajaj Markets, a financial marketplace, and Bajaj Technology Services, a techfin service provider.

Bajaj Markets is a marketplace that offers multiple financial products across all categories – Loans, Cards, Insurance, Investments, Payments, Pocket Insurance, and VAS. Bajaj Markets has partnered with trusted financial brands to offer “India ka Financial Supermarket.” A one-stop destination where its customers can explore a host of products that can help them achieve their financial life goals.

Having started its journey as a fintech, Bajaj Finserv Direct has also built a very strong business as a techfin. Through Bajaj Technology Services it offers a wide gamut of digital technology services which span Custom Applications, Enterprise Applications, Data & Analytics, Gen AI, Cloud Services and Digital Agency.

Visit the Bajaj Markets website or download the Bajaj Markets’ app from the Play Store or App Store to experience “India ka Financial Supermarket.”

The used car market has witnessed significant growth in recent years, driven by factors like increasing affordability, technological advancements, and changing consumer preferences. As the demand for used cars surges, understanding the nuances of interest rates on used car loans becomes crucial for potential buyers.

Insights into Used Car Loan Interest Rates Variation

Banks, NBFCs, and other financial institutions offer lucrative used car loan features, with low interest rates often being one of the key benefits of these loans.

Shriram Finance, one of the headliners in the NBFC (Non-Banking Financial Company) sector, offers Shriram Used Car Loan with an interest rate starting at 10%* p.a. This makes this reputed NBFC one of the top choices in the used car financing segment.

Factors Influencing Interest Rates on Used Car Loans

Several factors contribute to the variation in interest rates on used car loans, some of which are mentioned below:

• Credit Score: A higher credit score, usually 700+, often translates to lower interest rates.

• Loan Amount: Larger loan amounts may attract higher interest rates, as they pose a greater financial risk to lenders.

• Loan Tenure: Longer loan tenures typically result in higher interest rates, as the lenders exposure to risk increases over a longer period.

• Vehicle Age and Condition: Newer vehicles in excellent condition often qualify for lower interest rates.

• Margin Money: A substantial down payment or margin money can reduce the loan amount, potentially leading to lower interest rates.

• Financial Institutions Policies: Different financial institutions have varying interest rate policies. Comparing offers from multiple lenders can help you secure the best deal.

• Economic Factors: Economic indicators like inflation, interest rates set by the RBI, and overall market conditions can impact the interest rates offered on used car loans.

Tips for Securing the Best Interest Rate on a Used Car Loan

There are a few things that borrowers can do to enjoy lower interest rates on their used car loan:

• Improve Your Credit Score: Pay bills on time, maintain a low credit utilisation ratio, and avoid excessive debt. A higher credit score can significantly improve your chances of securing a lower interest rate.

• Shop Around for the Best Deal: Compare offers from multiple lenders to find the most competitive interest rate. Reputed NBFCs may offer lower interest rates than traditional banks.

• Consider a Larger Down Payment: A larger down payment can reduce the loan amount and potentially lower the interest rate. Try to arrange for a larger margin money to enjoy lower rates.

• Opt for a Shorter Loan Tenure: A shorter loan tenure can lead to lower interest payments over the long term.

• Negotiate with the Loan Provider: Do not hesitate to negotiate with your chosen loan provider to secure a better interest rate, especially if you have a strong credit history or an ongoing relationship with the bank or NBFC.

What Makes Shriram Used Car Loan a Compelling Choice

Shriram Finance provides a comprehensive range of features and benefits for its used car loan, designed to make the car-buying experience seamless and financially manageable for customers.

• Attractive Interest Rates: With interest rates starting as low as 10%* p.a., borrowers can finance their used car purchases without incurring excessive costs.

• Higher Financing: Customers can secure financing of up to 85%* of the used cars value.

• Flexible Repayment Tenures: With a repayment tenure of up to 48 months*, Shriram Finance provides flexibility that caters to individual financial situations.

• Easy Application: A simple online process helps prospective borrowers reduce the time and effort required to secure financing for their used car.

• Minimal Documentation: Shriram Finance simplifies the borrowing experience by requiring minimal paperwork.

• Fast Approval: Customers benefit from rapid loan approvals and disbursements, allowing them to access funds swiftly.

• User-Friendly EMI Calculator: The availability of an online EMI calculator empowers potential borrowers to estimate their monthly payments easily.

Conclusion
By understanding the factors that influence interest rates on used car loans and implementing effective strategies, prospective borrowers can significantly reduce their borrowing costs and accelerate their journey to automotive ownership. Shriram Finance, with its compelling used car loan features, including rates starting from 10%* p.a. stands out as one of the top choices in the market, ensuring borrowers can finance a used car of their dreams without a hassle.

*Above mentioned rates and tenure are as per the company’s Digital Used Car Loan Policy

About Shriram Finance
Shriram Finance is a leading diversified financial services company in India, offering a wide range of financial products and services across consumer, wholesale, and business finance segments. The company has a strong presence pan India with a network of 3,196 branches and an employee strength of 79,405 with an AUM of Rs. 254,469 crores. With a focus on financial inclusion and customer-centricity, Shriram Finance continues to empower individuals and businesses to achieve their financial goals.

With algorithmic trading accounting for nearly 60% of total market volumes in India, the demand for AI-powered platforms is at an all-time high. Artificial intelligence is no longer just a buzzword in the financial world-its rapidly transforming how markets operate. While institutional investors and hedge funds have long used AI-based trading models, this technology is now reaching retail traders, giving them access to professional-level tools. Todays retail investors need more than raw data; they want actionable insights, instant market analysis, and risk management strategies in easy-to-understand formats. This evolution has given rise to AI-powered trading platforms, with NeoTrader leading the way.

Combining Decades of Trading Experience and AI – The NeoTrader Advantage; NeoTrader Management (L to R): Raja Venkatraman, Dr. C. K. Narayan, Aditya Iyer

AIs Growing Role in Trading

AI technology has revolutionised the trading field. What began as basic algorithmic trading has evolved into sophisticated deep learning models that achieve remarkable accuracy in predicting market trends.

These AI systems analyse historical market data to identify patterns and generate automated trading signals far faster than any human analyst could.

The surging demand for AI trading tools is driven by:

• Increasing global market complexity

• The need for swift, data-driven trading decisions

• New retail traders seeking expert insights despite limited financial experience

• The rise of commission-free trading, making high-frequency strategies more accessible

• SEBI’s proposed framework to allow retail investors to participate in algo trading via stock brokers

According to a report by SEBI, proprietary traders and foreign investors dominate the algorithmic trading landscape, with retail participation still in its early stages. However, platforms like NeoTrader are changing the status quo by bringing advanced AI-powered solutions to retail traders.

When Technology Meets Four Decades of Expertise

“Were not just witnessing change – were seeing a complete reimagining of whats possible in retail trading”, declares Dr. C.K. Narayan, Founder of NeoTrader and a market veteran whose four-decade journey through Indias financial markets has been groundbreaking. “The traditional barriers between institutional and retail trading capabilities are not just lowering – theyre disappearing entirely.”

This vision materialized as NeoTrader, where advanced AI technology combines with deep market knowledge to deliver powerful trading solutions. By integrating real-time analysis, predictive modeling, and automated trading signals, NeoTrader helps traders make more informed market decisions with greater confidence.

For years, institutions held the upper hand through exclusive access to advanced technologies, data analytics, and market intelligence. Now, through platfirms such as NeoTrader, retail traders can access sophisticated AI-powered capabilities that simplify complexity while delivering professional-grade market analysis. According to various industry estimates, the number of active algo traders in the retail segment powered by tools like NeoTrader has grown by nearly 30% annually over the past five years.

“The democratization of sophisticated trading tools has been a game-changer,”Dr. Narayan emphasizes. “Were seeing remarkable success stories from traders who, just months ago, were complete newcomers to the market.”

The evolution extends beyond trading tools. Modern platforms increasingly emphasise educational resources and user empowerment. “The future of trading lies in combining powerful technology with proper education,” says Raja Venkatraman, Co-founder of NeoTrader, trading coach and trainer in the art of technical analysis. “Were seeing unprecedented engagement rates backed by strong educational foundation in the markets.”

As Indias retail trading community expands, AIs role in shaping trading decisions will grow accordingly. “The trend were seeing is clear”, notes Aditya Iyer, Co-founder and CEO of NeoTrader. “Traders who embrace AI-powered tools while maintaining disciplined trading practices are consistently outperforming their peers. Its not just about having powerful technology – its about using it intelligently.”

The Road Ahead

The Indian fintech industrys strong growth potential suggests that AI applications in trading will continue to evolve. This shift in trading practices marks a significant advancement in Indias financial market development. AIs role in democratising market access and improving trading outcomes will only increase as the technology advances.

“Were just scratching the surface of whats possible,” concludes Aditya Iyer. “The integration of human knowledge and AI technology creates opportunities that were unimaginable just a few years ago. Our users success stories demonstrate the tremendous potential of this powerful combination.”

This trading technology revolution represents a paradigm shift, serving as both an essential tool and a fundamental change in retail investors market strategies. As these platforms continue to evolve, they are transforming trading outcomes for market participants across the spectrum.

• Pankaj Tripathi becomes the brand ambassador for high-performance fuels at Jio-bp retailed at no extra cost

• Split Fuel Car unveiled showcasing how high-performance fuels at Jio-bp power smoothness in driving experience

Minister of Petroleum and Natural Gas, Shri. Hardeep Singh Puri today launched the International Fuel for India (IFFI) campaign of Jio-bp (the operating brand of Reliance BP Mobility Limited, a joint venture of Reliance Industries and bp), a leading mobility solution provider, at India Energy Week 2025 in New Delhi. Featuring popular Indian cinema actor, Pankaj Tripathi, IFFI campaign showcases how Jio-bp is taking high performance fuels to every Indian at no extra cost.

R to L :Honourable Minister of Petroleum & Natural Gas Shri. Hardeep Singh Puri, Secretary MoPNG Shri. Pankaj Jain and Jio-bp Leadership

Leveraging over 100 years of bp’s fuel research experience, Jio-bp’s high-performance fuels with ACTIVE Technology have been developed by testing Indian Original Equipment Manufacturer’s engines with Indian Fuel over thousands of Kms under the intense scrutiny of expert technologists at globally acclaimed R&D centers in United Kingdom and Germany. Diesel at Jio-bp with ACTIVE technology offers an incremental mileage benefit of up to 4.3%*, and petrol at Jio-bp with ACTIVE technology helps keep critical engine parts up to 10 times cleaner*.

High-performance fuels at Jio-bp work across all types of commercial and private vehicles alongside non-transport segment, helping to reduce engine wear & tear, to improve fuel economy & to lower need for unscheduled maintenance due to dirt congestion in engine parts. Powered by ACTIVE Technology, high-performance fuels at Jio-bp prevent harmful dirt accumulation, ensuring superior engine performance and better fuel efficiency while also extending lifespan of critical engine parts.

To help the country see this ACTIVE Technology “live” in action, Jio-bp unveiled the innovative Split Fuel Car at India Energy Week 2025 in New Delhi. Split Fuel Car has clearly demarcated two fuel tanks powering the different halves of the vehicle’s 6-cylinder engine. It is a transparent showcasing of how high-performance petrol at Jio-bp with ACTIVE Technology and ordinary petrol operate differently. With borescope imaging (used in medical field for looking inside human body), the exhibit showed higher deposits building up on critical engine components for ordinary petrol which would inevitably lead to lower fuel efficiency. Given the engine is running in the same car under same conditions, this is testimony to the benefit of operating with ACTIVE Technology powered fuels.

True to Jio-bp’s commitment of delivering “More” for India, Jio-bp is leveraging Reliance Industries Limited’s fuel supply chain, to democratize high-performance fuels. These fuels are available as the base offering at over 1875 country-wide Jio-bp mobility stations at no extra cost to customers.

*Terms and conditions apply. Pls visit Jio-bp website for more details.

About Jio-bp
Operating under the brand ‘Jio-bp’, Reliance BP Mobility Limited (RBML) is an Indian fuels and mobility joint venture between Reliance Industries Limited (RIL) and bp. The joint venture leverages Reliance’s presence across the country and its millions of consumers through the Jio digital platform. bp brings its extensive global experience in high-quality differentiated fuels, lubricants, retail, and advanced low carbon mobility solutions. In addition to marketing conventional fuels, RBML provides advanced mobility solutions and alternate fueling options to its customers such as Electric Vehicles (EV) charging points. The company’s aviation brand ‘air bp-Jio’ is a leading supplier of Aviation Turbine Fuel across India. The brand ‘Jio-bp Fuel4U’ caters to on-demand doorstep delivery of diesel and is a market leader in the segment.

Learn more about Jio-bp on www.jiobp.com / Twitter and Facebook: @Jiobpofficial/ For latest updates check out www.jiobp.com/news-room

In a bold step that promises to reshape the nation’s healthcare landscape, Pristyn Care has unveiled its first Super-specialty hospital in South Delhi. This state-of-the-art facility marks a significant milestone for the healthcare startup, which has rapidly grown to become a trusted name in secondary care across 25 cities in India.

Pristyn Care has unveiled its first Super-specialty hospital in South Delhi

The new hospital boasts four modular operating theatres (OTs) equipped with advanced technology, including a Level 3 Neonatal Intensive Care Unit (NICU), ensuring top-notch care for the youngest and most vulnerable patients. In addition, the facility boasts dedicated departments for dermatology and plastic surgery, equipped with high-end machines, further enhancing its comprehensive range of services.

Over the past five years, Pristyn Care has successfully performed 300,000 surgeries, even navigating the challenges posed by COVID-19. The company now facilitates over 3 million patient interactions per year and registers 100,000 surgery patients monthly.

“Our journey from leveraging partner facilities for surgeries to establishing our own hospital is the final frontier in delivering comprehensive, high-quality care,” said one of the Pristyn Care founders. The new hospital is a beacon of innovation in super-specialty healthcare. Pristyn Care operates across general surgery, ophthalmology, gynaecology, bariatrics, orthopedics, plastic surgery, and urology, making it a leader among India’s top multi-specialty secondary care providers. The launch of the South Delhi hospital signals a strategic evolution for Pristyn Care, shifting from an asset-light model to a dedicated hospital. Healthcare experts note that integrating digital innovation with physical infrastructure sets a new benchmark in healthcare delivery.

Pristyn Care plans to open 50 hospitals in the next three years across 25 cities, ensuring top-tier medical services are readily accessible and improving treatment outcomes and patient satisfaction. To support its expansion, Pristyn Care aims to grow its healthcare workforce to 3,500+ staff and 750+ surgeons, enhancing its ability to provide specialized care.

As the surgery business approaches INR 500+ Cr in FY 25, Pristyn Care has also reduced EBITDA burn by 60% year-over-year, demonstrating sustainable growth and financial stability. Pristyns advanced software technology ensures seamless integration of administrative and medical functions, enhancing transparency, streamlining operations, and ensuring superior patient care.

As Pristyn Care continues to push the boundaries of patient-centric care, the new South Delhi hospital is poised to serve as a hub of excellence. With its commitment to innovation and accessibility, the company is set to redefine the future of multi-specialty secondary care nationwide.

• To acquire R&D center at Saint-Julien-en-Genevois, France

• To add Drug Discovery & Preclinical Development capabilities in Biologics & Antibody Drug Conjugate

Jubilant Biosys Innovative Research Services Pte. Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, has executed the transaction definitive agreements with Pierre Fabre SA, and its affiliate entities (“PF”), for JBIRSPL to acquire 80% equity capital in JASMIN (new company incorporated by PF in France, as a Societe par Actions Simplifiee (SAS)), with remaining 20% retained by PF.

R&D center at Saint-Julien-en-Genevois, France

At closing of the transaction, JASMIN shall acquire Pierre Fabre’s R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders’ Agreement and other transition agreements with PF.

Strategic Rationale
This strategic agreement will enable Jubilant Biosys Limited to expand its footprint in Europe in areas like Biologics (mAbs) and Antibody Drug Conjugate (ADC), in addition to its existing services including integrated drug discovery services from India

• Expands Jubilant’s addressable market in the fast-growing (20%+ CAGR) ADC/XDC segment: Expands Jubilant’s addressable market in ADC CDMO to ~$1.4 Bn. Next gen XDCs pipeline is also growing rapidly

• Enhances Jubilant Biosys Limited’s domain expertise in ADC with expanded chemistry capabilities: Complements Jubilant Biosys Limited‘s payload expertise with payload-linker synthesis, bioconjugation and analytical services

• PF team have deep ADC/XDC expertise: Core team with decades of ADC experience, with history of successfully delivering several clinical candidates

• Provides strategic footprint in EU: An opportunity to significantly expand our customer connections with large pharmaceutical companies due to proximity to EU/US markets, which have a preference for local CRO interactions

• Brings together a complementary innovator customer base: The collaboration will help create significant cross-selling potential to customer bases across small-to-mid biotech and large innovator pharma

• Unique & cost-effective delivery model: Integrating the scientific expertise in Biologics at the Saint-Julien-en- Genevois site with that of small molecules at Jubilant will provide a unique & cost-effective delivery model to EU & US Companies.

Speaking on the announcement, Giuliano Perfetti, CEO & Managing Director, Jubilant Biosys Limited said, “We are thrilled to have reached this strategic agreement with Pierre Fabre. Our R&D site in Saint-Julien-en-Genevois will serve as a Center of Excellence for biologics and ADCs, located at the heart of Europe. This expansion strengthens our presence and fosters collaboration with both biotech and large pharma companies in Europe and the USA. By combining the scientific expertise in biologics and ADCs at Saint-Julien-en-Genevois with the capabilities of 1,200 scientists in India we establish a comprehensive service offering for accelerated delivery of early chemistry, discovery biology, DMPK, integrated drug discovery and CDMO for intermediates and APIs. With this strategic move, Jubilant Biosys Limited advances its “CRDMO Partner in Science” strategy and reinforces its commitment to delivering innovative solutions to global pharmaceutical customers.”

About Jubilant Biosys Limited
Jubilant Biosys Limited provides drug discovery and contract development and manufacturing services to global pharmaceutical and biotech companies. The service offering includes drug discovery services, mg to Kilo, non-GMP and GMP scale up of novel compounds, intermediates and NCEs. The business operates from Bengaluru, Noida and Greater Noida in India, offering integrated and functional drug discovery and development services to global innovators. Jubilant Biosys Limited has demonstrated expertise in functional services in chemistry including computational, medicinal/ synthetic chemistry, PR&D and GMP scale-up capabilities up to phase II. Services in biology include structural biology, in-vitro biology, DMPK, in-vivo pharmacology and Toxicology. Further, Jubilant Biosys Limited has integrated discovery expertise with a track record of working on over 85 programs in multiple therapeutic areas including but not limited to Oncology, Metabolic Disorders, Pain & Inflammation, CNS and expanding into Rare Diseases.

About Jubilant Pharmova Limited
Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses. In the Radiopharma business, the Company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radiopharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. Jubilant through its CDMO Sterile Injectable business offers manufacturing services including sterile fill and finish injectable (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules. The CRDMO business of the Company includes the Drug Discovery Services business that provides contract research and development services through two world class research centers in Bengaluru and Noida in India and the CDMO-API business that is involved in the manufacturing of Active Pharmaceutical Ingredients. Jubilant Therapeutics is involved in Proprietary Novel Drugs business and is an innovative biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders. The Company operates multiple manufacturing facilities that cater to all the regulated market including USA, Europe and other geographies. Jubilant Pharmova Limited has a team of around 5,500 multicultural people across the globe. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals companies globally.

Brief about Pierre Fabre
Laboratoires Pierre Fabre, established in 1961 by pharmacist Pierre Fabre, is a leading French multinational company headquartered in Castres, France. Specializing in pharmaceuticals and dermo-cosmetics, the company has grown to employ over 10,000 people worldwide. In 2023, the company reported revenues exceeding €2.8 billion, with 70% of sales generated internationally. Renowned for its innovation in oncology and dermatology, Pierre Fabre has become a significant global player in the healthcare and beauty industries.

The Research Centre in Saint-Julien-en-Genevois was founded by Pierre Fabre in January 1990. It specializes in immuno-oncology, with a focus on immunomodulatory macrophage biomedicines. Over the years, it has also developed a strong expertise in biological drugs, naked antibodies, and antibody-drug conjugates (ADCs). Located near Geneva and immerged in a particularly buoyant pharmaceutical innovation ecosystem on both sides of the border, the site enjoys state-of-the-art expertise and equipment and is pursuing several research projects on the reactivation of macrophage activity in case of cancer inhibition.

Disclaimer
Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential product characteristics and uses, product sales potential and target dates for product launch are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Jubilant Pharmova Limited may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the regulatory bodies and its reports to shareholders. The company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

‘Saint-Julien-en-Genevois‘ refers to – “Saint-Julien-en-Genevois at the France/Switzerland border“